Thomas Stevens, CFA" »

Aeglea Biotherapeutics shares owned by Thomas Stevens, CFA"

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Thomas Stevens, CFA" from 13F filings

Historical chart of Thomas Stevens, CFA" investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Thomas Stevens, CFA" consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Thomas Stevens, CFA"

Quarter filed Position value Share count Share price at filing
2025-12-31 $313k 13k 24.26
2025-09-30 $305k 18k 16.76

More positions owned by Thomas Stevens, CFA"

NVIDIA Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Microsoft Corp Common Stock (MSFT)
Broadcom Common Stock (AVGO)
Meta Platforms Common Stock (META)
Amazon.com Common Stock (AMZN)
Alphabet Common Stock (GOOG)
Alphabet Common Stock (GOOGL)
Netflix Common Stock (NFLX)
AbbVie Common Stock (ABBV)
Gilead Sciences Common Stock (GILD)
Tesla Common Stock (TSLA)
General Electric Common Stock (GE)
Merck & Co Common Stock (MRK)
Amphenol Corp Common Stock (APH)

View all positions for Thomas Stevens, CFA"

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics